4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-23-012587
Chief R&D Officer sold 7,000 shares at $8.29 ($58,030)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Thackray Helen M. · Chief R&D Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-04-03 | Sale : show line 1 in the form 10b5-1 | −7,000 | $8.29 | $58,030 | 207,275 | D |
| Open-market sales · 7,000 sh · avg $8.29 · $58,030 | ||||||
Loading xslF345X04/form4.xml…